Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain
Clinical trial NCT02423577 · COMPLETED
Trial details
- NCT number
- NCT02423577
- Sponsor
- Autoimmune Technologies, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-06-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.